pharma · Colon Carcinoma Metastatic in the Liver · Metastatic Melanoma · VCNX
Vaccinex
VACCINEX, INC.
Vaccinex is a pharma organization headquartered in Rochester, USA. It trades on NYSE under ticker VCNX. Primary therapeutic focus areas include Colon Carcinoma Metastatic in the Liver, Metastatic Melanoma, Metastatic Pan
1895 Mt Hope Ave, Rochester, New York 14620, US HQ
28 Employees
Public company Type
VCNX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1895 Mt Hope Ave, Rochester, New York 14620, US
- Employees
- 28
- Programs
- 11
- Drugs
- 8
- Patents
- 41
Anti-SEMA4D Monoclonal Antibody VX15/2503
Phase 1 · mab · Metastatic Melanoma
Anti-SEMA4D Monoclonal Antibody VX15/2503 for Metastatic Melanoma is a Phase 1 program (mab) at VACCINEX, INC. with 1 ClinicalTrials.gov record(s).
Internal code 17-001570
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- VACCINEX, INC.
- Phase
- Phase 1
- Modality
- mab
- Indication
- Metastatic Melanoma
- Status
- terminated
- Trials
- 1